Skip to the page

Data / Form D filings / NeuroCytonix Inc.

NeuroCytonix Inc.: Form D filing

NeuroCytonix Inc., a technology company in Rockville, MD, filed a Form D with the SEC in 2023. The latest, on April 11, 2023, reports $4 million sold of an offering with no set size to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2273 RESEARCH BOULEVARD, SUITE 725, Rockville, MD, 20850
Phone
(240) 243-6455
Industry
Other Technology
Entity type
Corporation
Incorporated in
Maryland
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1966934

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 11, 2023New noticeIndefinite$4,010,33718Feb 6, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
J. Roberto TrujilloExecutive Officer, Director
Michael Roberto BattDirector
Rodrigo Roberto GarciaDirector
Laurent Roberto Lavigne du CadetExecutive Officer, Director
Armando Roberto RequejoDirector
Jeff Roberto BalagnaDirector

Other technology companies in Maryland that filed recently

Every Form D from the week of Apr 10, 2023 · All recent filings in Maryland · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what NeuroCytonix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.